DAVID LISKOV: Open Payments
NPI 1780683417 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 52 payments from 10 companies in 2025. Trend: 2023 $443 · 2024 $559 · 2025 $960
Food & beverage: $850Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $260 |
| Otsuka America Pharmaceutical, Inc. | 10 | $174 |
| E.R. Squibb & Sons, L.L.C. | 7 | $140 |
| Vanda Pharmaceuticals Inc. | 5 | $117 |
| Janssen Pharmaceuticals, Inc | 4 | $82 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Sage Therapeutics, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $10 |
Products named: COBENFY, REXULTI, FANAPT, UZEDY, INGREZZA, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
